Konsulentfirmaet LG Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 44845016
Stevnsvej 79, Strøby Egede 4600 Køge
Income statement (kDKK)
2024 | |
---|---|
Fiscal period length | 12 |
Net sales | |
Gross profit | 768.17 |
Employee benefit expenses | - 680.27 |
Total depreciation | -60.00 |
EBIT | 27.90 |
Other financial expenses | -0.07 |
Pre-tax profit | 27.83 |
Income taxes | -9.52 |
Net earnings | 18.31 |
Assets (kDKK)
2024 | |
---|---|
Goodwill | 540.00 |
Intangible assets total | 540.00 |
Tangible assets total | |
Investments total | |
Long term receivables total | |
Inventories total | |
Current trade debtors | 75.68 |
Prepayments and accrued income | 33.77 |
Short term receivables total | 109.46 |
Cash and bank deposits | 171.00 |
Cash and cash equivalents | 171.00 |
Balance sheet total (assets) | 820.46 |
Equity and liabilities (kDKK)
2024 | |
---|---|
Share capital | 40.00 |
Shares repurchased | 135.00 |
Retained earnings | 293.00 |
Profit of the financial year | 18.31 |
Shareholders equity total | 486.31 |
Provisions | 118.80 |
Non-current liabilities total | |
Current trade creditors | 18.00 |
Short-term deferred tax liabilities | 22.72 |
Other non-interest bearing current liabilities | 174.63 |
Current liabilities total | 215.35 |
Balance sheet total (liabilities) | 820.46 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.